Tianshui Zhongxing Bio-technology Co.,Ltd. Share Price

Equities

002772

CNE1000020B6

Fishing & Farming

End-of-day quote Shenzhen S.E. 03:30:00 30/04/2024 am IST 5-day change 1st Jan Change
7.08 CNY -.--% Intraday chart for Tianshui Zhongxing Bio-technology Co.,Ltd. +1.87% -10.27%

Financials

Sales 2022 1.97B 272M 22.7B Sales 2023 1.93B 267M 22.25B Capitalization 3.1B 429M 35.75B
Net income 2022 158M 21.82M 1.82B Net income 2023 160M 22.1M 1.84B EV / Sales 2022 2.12 x
Net Debt 2022 907M 125M 10.45B Net Debt 2023 761M 105M 8.77B EV / Sales 2023 2 x
P/E ratio 2022
20.8 x
P/E ratio 2023
20.2 x
Employees 5,761
Yield 2022
3.61%
Yield 2023
3.8%
Free-Float 51.43%
More Fundamentals * Assessed data
Dynamic Chart
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tianshui Zhongxing Bio-technology’s Profit Seen Tripling in 2022 MT
Zhongxing Bio-technology to Pay Interest on 920 Million Yuan Convertible Bond MT
Zhongxing Bio-technology Unit Halts Production on COVID-19 Outbreak MT
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Tianshui Zhongxing Bio-technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Tianshui Zhongxing Bio-Technology Scraps Plan to Buy Wine Company CI
More news
1 week+1.87%
Current month-8.65%
1 month-8.65%
3 months-4.07%
6 months-15.61%
Current year-10.27%
More quotes
1 week
6.78
Extreme 6.78
7.21
1 month
6.46
Extreme 6.46
7.84
Current year
5.47
Extreme 5.47
9.63
1 year
5.47
Extreme 5.47
11.38
3 years
5.47
Extreme 5.47
17.24
5 years
5.47
Extreme 5.47
17.24
10 years
5.47
Extreme 5.47
31.44
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 01/11/01
Chairman 39 01/11/01
Director of Finance/CFO 38 28/18/28
Members of the board TitleAgeSince
Corporate Officer/Principal 52 01/07/01
Chief Executive Officer 50 01/11/01
Chairman 50 01/12/01
More insiders
Date Price Change Volume
30/24/30 7.08 -.--% 6,290,854
29/24/29 7.08 +2.16% 9,104,314
26/24/26 6.93 -3.75% 13,515,190
25/24/25 7.2 +2.56% 7,971,197
24/24/24 7.02 -.--% 5,603,028

End-of-day quote Shenzhen S.E., April 30, 2024

More quotes
Tianshui Zhongxing Bio-technology Co., Ltd. is principally engaged in the research and development, production and sale of edible mushroom. The Company's edible mushroom products include enoki mushroom, king oyster mushroom and beech mushroom. Through its subsidiaries, the Company also involves in the production and sale of edible mushroom, medicinal mushroom and auxiliary materials, research and development, application and promotion of microbial technology, biological engineering technology and new agricultural technologies, as well as the manufacture, process and distribution of agricultural by-products.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002772 Stock